Brenner MK - Search Results

1

Gene and cell transfer for specific immunotherapy.

Brenner MK, Heslop HE, Rooney CM. Brenner MK, et al. Vox Sang. 1998;74 Suppl 2:87-90. doi: 10.1111/j.1423-0410.1998.tb05401.x. Vox Sang. 1998. PMID: 9704428 Review.

2

Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant in patients with ALL.

Naik S, Vasileiou S, Tzannou I, Kuvalekar M, Watanabe A, Robertson C, Lapteva N, Tao W, Wu M, Grilley B, Carrum G, Kamble RT, Hill L, Krance RA, Martinez C, Tewari P, Omer B, Gottschalk S, Heslop HE, Brenner MK, Rooney CM, Vera JF, Leen AM, Lulla PD. Naik S, et al. Among authors: brenner mk. Blood. 2022 Apr 28;139(17):2706-2711. doi: 10.1182/blood.2021014648. Blood. 2022. PMID: 35134127 Free PMC article.

3

EBV specific CTL: a model for immune therapy.

Rooney CM, Heslop HE, Brenner MK. Rooney CM, et al. Among authors: brenner mk. Vox Sang. 1998;74 Suppl 2:497-8. doi: 10.1111/j.1423-0410.1998.tb05463.x. Vox Sang. 1998. PMID: 9704488 Review.

4

Immunotherapy for Epstein-Barr virus-associated cancers.

Rooney CM, Roskrow MA, Smith CA, Brenner MK, Heslop HE. Rooney CM, et al. Among authors: brenner mk. J Natl Cancer Inst Monogr. 1998;(23):89-93. doi: 10.1093/oxfordjournals.jncimonographs.a024180. J Natl Cancer Inst Monogr. 1998. PMID: 9709309

5

Treatment of relapsed Hodgkin's disease using EBV-specific cytotoxic T cells.

Rooney CM, Roskrow MA, Suzuki N, Ng CY, Brenner MK, Heslop H. Rooney CM, et al. Among authors: brenner mk. Ann Oncol. 1998;9 Suppl 5:S129-32. doi: 10.1093/annonc/9.suppl_5.s129. Ann Oncol. 1998. PMID: 9926252 Clinical Trial.

6

Transfer of EBV-specific CTL to prevent EBV lymphoma post bone marrow transplant.

Heslop HE, Perez M, Benaim E, Rochester R, Brenner MK, Rooney CM. Heslop HE, et al. Among authors: brenner mk. J Clin Apher. 1999;14(3):154-6. doi: 10.1002/(sici)1098-1101(1999)14:3<154::aid-jca9>3.0.co;2-k. J Clin Apher. 1999. PMID: 10540372 Review.

7

An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs.

Gottschalk S, Ng CY, Perez M, Smith CA, Sample C, Brenner MK, Heslop HE, Rooney CM. Gottschalk S, et al. Among authors: brenner mk. Blood. 2001 Feb 15;97(4):835-43. doi: 10.1182/blood.v97.4.835. Blood. 2001. PMID: 11159505 Free article.

8

Adoptive immunotherapy of EBV-associated malignancies with EBV-specific cytotoxic T-cell lines.

Rooney CM, Aguilar LK, Huls MH, Brenner MK, Heslop HE. Rooney CM, et al. Among authors: brenner mk. Curr Top Microbiol Immunol. 2001;258:221-9. doi: 10.1007/978-3-642-56515-1_14. Curr Top Microbiol Immunol. 2001. PMID: 11443864 Review. No abstract available.

9

Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus--positive Hodgkin's lymphoma.

Gahn B, Siller-Lopez F, Pirooz AD, Yvon E, Gottschalk S, Longnecker R, Brenner MK, Heslop HE, Aguilar-Cordova E, Rooney CM. Gahn B, et al. Among authors: brenner mk. Int J Cancer. 2001 Sep 1;93(5):706-13. doi: 10.1002/ijc.1396. Int J Cancer. 2001. PMID: 11477583

10

Generation of autologous Epstein-Barr virus-specific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipients.

Savoldo B, Goss J, Liu Z, Huls MH, Doster S, Gee AP, Brenner MK, Heslop HE, Rooney CM. Savoldo B, et al. Among authors: brenner mk. Transplantation. 2001 Sep 27;72(6):1078-86. doi: 10.1097/00007890-200109270-00017. Transplantation. 2001. PMID: 11579304

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

458 results

Search Page

Filters